Cardiotoxicity of Oncologic Treatments
The possibility of getting a cardiovascular disease or cancer increases with advancing age. At the same time, relevant improvements in cancer therapy have resulted in the improvement of quality of life and the increasement of the survival rate of such patients. As a result we have larger number of p...
Պահպանված է:
| Ձևաչափ: | Online |
|---|---|
| Լեզու: | անգլերեն |
| Հրապարակվել է: |
IntechOpen
2021
|
| Խորագրեր: | |
| Առցանց հասանելիություն: | ONIX_20210420_9789535102731_1270 |
| Ցուցիչներ: |
Չկան պիտակներ, Եղեք առաջինը, ով նշում է այս գրառումը!
|
| _version_ | 1869526513116774400 |
|---|---|
| collection | Directory of Open Access Books |
| description | The possibility of getting a cardiovascular disease or cancer increases with advancing age. At the same time, relevant improvements in cancer therapy have resulted in the improvement of quality of life and the increasement of the survival rate of such patients. As a result we have larger number of patients that experience the cardiac side effects of chemotherapy. The extent of cardiotoxicity is variable, depending on the type of drug used, combination with other drugs, prior mediastinal radiotherapy and the presence of cardiovascular risk factors or history of heart disease. Early detection of the patients proneness for developing cardiotoxicity is the key issue to decrease morbidity and mortality. It also facilitates more tailored therapeutic interventions. Therefore, the collaboration and interaction of cardiology and oncology may contribute to reducing the cardiovascular adverse effects and improving the results in the treatment of patients with cancer. |
| format | Online |
| id | doab-20.500.12854ir-65912 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | IntechOpen |
| publisherStr | IntechOpen |
| record_format | ojs |
| spelling | doab-20.500.12854ir-659122024-03-31T22:44:04Z Cardiotoxicity of Oncologic Treatments Fiuza, Manuela Cardiovascular medicine thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine The possibility of getting a cardiovascular disease or cancer increases with advancing age. At the same time, relevant improvements in cancer therapy have resulted in the improvement of quality of life and the increasement of the survival rate of such patients. As a result we have larger number of patients that experience the cardiac side effects of chemotherapy. The extent of cardiotoxicity is variable, depending on the type of drug used, combination with other drugs, prior mediastinal radiotherapy and the presence of cardiovascular risk factors or history of heart disease. Early detection of the patients proneness for developing cardiotoxicity is the key issue to decrease morbidity and mortality. It also facilitates more tailored therapeutic interventions. Therefore, the collaboration and interaction of cardiology and oncology may contribute to reducing the cardiovascular adverse effects and improving the results in the treatment of patients with cancer. 2021-04-20T15:29:09Z 2021-04-20T15:29:09Z 2012 book ONIX_20210420_9789535102731_1270 9789535102731 9789535168935 https://directory.doabooks.org/handle/20.500.12854/65912 eng image/jpeg n/a https://www.intechopen.com/books https://mts.intechopen.com/storage/books/1734/authors_book/authors_book.pdf IntechOpen IntechOpen 10.5772/2170 10.5772/2170 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 9789535102731 9789535168935 IntechOpen 196 open access |
| spellingShingle | Cardiovascular medicine thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine Cardiotoxicity of Oncologic Treatments |
| title | Cardiotoxicity of Oncologic Treatments |
| title_full | Cardiotoxicity of Oncologic Treatments |
| title_fullStr | Cardiotoxicity of Oncologic Treatments |
| title_full_unstemmed | Cardiotoxicity of Oncologic Treatments |
| title_short | Cardiotoxicity of Oncologic Treatments |
| title_sort | cardiotoxicity of oncologic treatments |
| topic | Cardiovascular medicine thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine |
| topic_facet | Cardiovascular medicine thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine |
| url | ONIX_20210420_9789535102731_1270 |